Cargando…
Measurement of Sarcopenia in Head and Neck Cancer Patients and Its Association With Frailty
In head and neck cancer (HNC) there is a need for more personalized treatment based on risk assessment for treatment related adverse events (i.e. toxicities and complications), expected survival and quality of life. Sarcopenia, defined as a condition characterized by loss of skeletal muscle mass and...
Autores principales: | de Bree, Remco, Meerkerk, Christiaan D. A., Halmos, Gyorgy B., Mäkitie, Antti A., Homma, Akihiro, Rodrigo, Juan P., López, Fernando, Takes, Robert P., Vermorken, Jan B., Ferlito, Alfio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150392/ https://www.ncbi.nlm.nih.gov/pubmed/35651790 http://dx.doi.org/10.3389/fonc.2022.884988 |
Ejemplares similares
-
Managing Cachexia in Head and Neck Cancer: a Systematic Scoping Review
por: Mäkitie, Antti A., et al.
Publicado: (2022) -
Value and Quality of Care in Head and Neck Oncology
por: Takes, Robert P., et al.
Publicado: (2020) -
Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era
por: Saba, Nabil F., et al.
Publicado: (2022) -
Vitamin D in Head and Neck Cancer: a Systematic Review
por: Mäkitie, Antti, et al.
Publicado: (2020) -
Lymph Node Metastases from Non-Melanoma Skin Cancer of the Head and Neck †
por: Civantos, Francisco, et al.
Publicado: (2023)